05:40:33 EDT Mon 02 Aug 2021
Enter Symbol
or Name

Login ID:
Trutrace Technologies Inc
Symbol TTT
Shares Issued 110,061,732
Close 2021-05-14 C$ 0.08
Recent Sedar Documents

ORIGINAL: Trutrace posts Q&A video with CEO Galarza

2021-05-14 23:06 ET - News Release

Received by email:

File: '\\doc\emailin\20210514 192635 Attachment 20210514 TruTrace Q&A Video Press Release(FINAL).docx'

TruTrace Technologies Publishes Q&A Video with CEO Robert Galarza

TORONTO, May 14, 2021 - TruTrace Technologies Inc. (CSE: TTT)) ("TruTrace" or the "Company"), creator of the first ful
--->ly-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, has today
---> published a video interview with CEO Robert Galarza where he answers questions from shareholders about the Company, i
--->ts technology, and future plans. The video will be made available on all of the Company's social media channels, as we
--->ll as available to watch on TruTrace's YouTube channel via this link: https://www.youtube.com/watch?v=tijbzHh4MSA

About TruTrace Technologies: www.trutrace.co:

TruTrace Technologies is the developer of a fully integrated software platform, secured on the blockchain, offering cl
--->ients the ability to store, manage, share and immediately access quality assurance and testing details, COAs, as well 
--->as motion and movement intelligence on inventory. The platform was specifically designed to power the traceability of 
--->testing standards within the legal cannabis, nutraceutical, food and pharmaceutical space with a focus on the authenti
--->cation of source materials or ingredients used in formulation.

For More Information: 

Robert Galarza, CEO
Tel: 888-775-4888
Email:  info@trutrace.co

Twitter: @TruTraceTech
LinkedIn: @trutracetech
Facebook: https://www.facebook.com/TruTrace/
Instagram: @trutracetechnologies

Disclaimer for Forward-Looking Information

This news release includes forward-looking information within the meaning of Canadian securities legislation, concerni
--->ng the business of TruTrace, including statements regarding general trends within the cannabis, nutraceutical and well
--->ness products industry, legislative frameworks for the legalization of cannabis and hemp-derived products, as well as 
--->current clients/commercial agreements/partnerships, such as in news releases we had on our system that were more of th
--->e 'corporate update' variety and not tied to a specific material change.
Although the Company believes that the expectations and assumptions on which such forward-looking information is based
---> are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give n
--->o assurance that it will prove to be correct and actual results and future events could differ materially from those a
--->nticipated in such information. Forward-looking information necessarily involves known and unknown risks, including, w
--->ithout limitation, risks associated with: general economic conditions; adverse industry events; loss of markets; futur
--->e legislative and regulatory developments in Canada, the United States, and elsewhere; inability to access sufficient 
--->capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; and oth
--->er risks beyond the Company's control. Events or circumstances may cause actual results to differ materially from thos
--->e predicted, as a result of numerous known and unknown risks, uncertainties and other factors, many of which are beyon
--->d the control of the Company. Readers are cautioned not to place undue reliance on any forward-looking information con
--->tained in this news release. Forward-looking information contained in this news release is provided as of the date of 
--->this news release. The Company disclaims any intent or obligation to update publicly any forward-looking information, 
--->whether as a result of new information, future events or results or otherwise, other than as required by applicable se
--->curities laws.

© 2021 Canjex Publishing Ltd. All rights reserved.